職稱英語(yǔ)衛(wèi)生b完型填空講義-wenkub
2022-09-02 20:42:04 本頁(yè)面
【正文】 safely enjoy vigorous petitive sports, but most older persons do better to limit themselves to less strenuous activities. Walking, swimming, skating are among the sports that one can enjoy and safely participate in throughout life. Regularity is important if one is to get the most enjoyment and benefit out of exercise. *6 Oncedaily Pill Could Simplify HIV Treatment BristolMyers Myers Squibb and Gilead Sciences have bined many HIV drugs into a single pill Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and HIV/AIDS,2 for example, are all treated with binations of drugs. But that can mean a lot of pills to take. It would be simpler if drug panies bined all the medicines into a single pill, taken just once a day. Now, two panies say they have done that for people just starting treatment for HIV, the virus that causes AIDS. The panies are BristolMyers Squibb and Gilead Sciences. They have developed a single pill that bines three drugs currently on the BristolMyers Squibb sells one of them under the name of Gilead bined the others, Emtriva and Viread, into a single pill in two thousand four. Combining drugs involves more than technical issues. It also involves issues of petition if the drugs are made by different panies. The new oncedaily pill is the result of what is described as the first joint venture agreement of its kind in the treatment of HIV In January the New England Journal of Medicine5 published a study of the new pill. Researchers pared its effectiveness to6 that of the widely used bination of Sustiva and Combivir. Combivir contains two drugs, AZT7 and The researchers say that after one year of treatment, the new pill suppressed HIV levels in more patients and with fewer side Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine in Baltimore, Maryland, led the research. He is a paid adviser to Gilead and BristolMeyers Squibb as well as the maker of Combivir, GlaxoSmithKline. Glaxo Smith Kline reacted to the findings by saying that a single study is of limited value. It says the effectiveness of Combivir has been shown in each of more than fifty studies. The price of the new oncedaily pill has not been announced. But Gilead and BristolMyers Squibb say they will provide it at reduced cost to developing countries. They plan in the next few months to ask the United States Food and Drug Administration10 to approve the new pill. There are limits to who could take it because of the different drugs it contains. For example, pregnant women are told not to take Sustiva because of the risk of birth Experts say more than forty million people around the world are living with HIV *9 Many Women Who Beat Cancer Don39。m on, as far as the vitamins, the diet, and the fitness. And I can39。t listening. Colon cancer survivors who exercise have actually been shown to have improved survival rates. So, yes, it is true that perhaps by making some of these health y choices we can actually increase their health, says Paskett. As a breast cancer survivor herself , Paskett knows first hand how much difference diet and exercise can make The challenge, she says, is to get more survivors to be more like Beth, during and after treatment. Experts say exercising more and eating a healthier diet can also cut down on stress and help women overe depression. There are more than 2 million breast cancer survivors living in the . Of those, nearly a million have yet to change their diet or exercise routines. *10 Hospital Mistreatment Ac
研究報(bào)告相關(guān)推薦
鄂ICP備17016276號(hào)-1